BEXBEVOR Trademark

Trademark Overview


On Thursday, October 13, 2022, a trademark application was filed for BEXBEVOR with the United States Patent and Trademark Office. The USPTO has given the BEXBEVOR trademark a serial number of 97631028. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Thursday, September 21, 2023. This trademark is owned by Pfizer Inc.. The BEXBEVOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for treatment of dermatomyositis
bexbevor

General Information


Serial Number97631028
Word MarkBEXBEVOR
Filing DateThursday, October 13, 2022
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateThursday, September 21, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 5, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for treatment of dermatomyositis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code8 - Abandoned
Class Status DateThursday, September 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Trademark Events


Event DateEvent Description
Thursday, September 21, 2023ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Thursday, September 21, 2023ABANDONMENT - AFTER PUBLICATION
Monday, September 18, 2023TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, September 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 5, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 16, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 2, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, August 2, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 2, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, August 2, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, July 27, 2023ASSIGNED TO EXAMINER
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 17, 2022NEW APPLICATION ENTERED